112 related articles for article (PubMed ID: 27470553)
1. Nanomedicine-based combination of gambogic acid and retinoic acid chlorochalcone for enhanced anticancer efficacy in osteosarcoma.
Liu L; Qi XJ; Zhong ZK; Zhang EN
Biomed Pharmacother; 2016 Oct; 83():79-84. PubMed ID: 27470553
[TBL] [Abstract][Full Text] [Related]
2. Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma.
Qin YG; Zhu LY; Wang CY; Zhang BY; Wang QY; Li RY; Liu Z
Lipids Health Dis; 2015 Jul; 14():70. PubMed ID: 26170203
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid.
Yao J; Li Y; Sun X; Dahmani FZ; Liu H; Zhou J
Int J Nanomedicine; 2014; 9():3313-24. PubMed ID: 25045262
[TBL] [Abstract][Full Text] [Related]
4. A solvent-assisted active loading technology to prepare gambogic acid and all-trans retinoic acid co-encapsulated liposomes for synergistic anticancer therapy.
Na K; Liu K; Yu J; Wang X; Li M; Tian C; He H; He Y; Wang Y
Drug Deliv Transl Res; 2020 Feb; 10(1):146-158. PubMed ID: 31529371
[TBL] [Abstract][Full Text] [Related]
5. Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy.
Ding Y; Wang Y; Opoku-Damoah Y; Wang C; Shen L; Yin L; Zhou J
Biomaterials; 2015 Dec; 72():90-103. PubMed ID: 26344366
[TBL] [Abstract][Full Text] [Related]
6. Gambogic acid inhibits the growth of osteosarcoma cells in vitro by inducing apoptosis and cell cycle arrest.
Zhao W; Zhou SF; Zhang ZP; Xu GP; Li XB; Yan JL
Oncol Rep; 2011 May; 25(5):1289-95. PubMed ID: 21331449
[TBL] [Abstract][Full Text] [Related]
7. Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
Li S; Xiong Y; Zhang X
Biomed Pharmacother; 2017 Jun; 90():872-879. PubMed ID: 28449430
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide-loaded poly (lactic-co-glycolic acid) PLGA-dextran polymeric nanoparticles to improve the antitumor efficacy in Osteosarcoma.
Chen B; Yang JZ; Wang LF; Zhang YJ; Lin XJ
BMC Cancer; 2015 Oct; 15():752. PubMed ID: 26486165
[TBL] [Abstract][Full Text] [Related]
9. Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer.
Zhang D; Chu Y; Qian H; Qian L; Shao J; Xu Q; Yu L; Li R; Zhang Q; Wu F; Liu B; Liu Q
Int J Nanomedicine; 2020; 15():735-747. PubMed ID: 32099362
[TBL] [Abstract][Full Text] [Related]
10. Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance.
Wang S; Yang Y; Wang Y; Chen M
Int J Pharm; 2015 Nov; 495(2):840-8. PubMed ID: 26407923
[TBL] [Abstract][Full Text] [Related]
11. Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment.
Zhang Z; Qian H; Yang M; Li R; Hu J; Li L; Yu L; Liu B; Qian X
Int J Nanomedicine; 2017; 12():1593-1605. PubMed ID: 28280328
[TBL] [Abstract][Full Text] [Related]
12. A multiple environment-sensitive prodrug nanomicelle strategy based on chitosan graftomer for enhanced tumor therapy of gambogic acid.
Du Q; Lv F; Huang J; Tang X; Zhao Z; Chen J
Carbohydr Polym; 2021 Sep; 267():118229. PubMed ID: 34119182
[TBL] [Abstract][Full Text] [Related]
13. Improved druggability of gambogic acid using core-shell nanoparticles.
Liu F; Huang X; Han L; Sang M; Hu L; Liu B; Duan B; Jiang P; Wang X; Qiao Z; Ma C; Liu W; Liu J; Feng F; Qu W
Biomater Sci; 2019 Feb; 7(3):1028-1042. PubMed ID: 30608065
[TBL] [Abstract][Full Text] [Related]
14. miR-542-3p Appended Sorafenib/All-trans Retinoic Acid (ATRA)-Loaded Lipid Nanoparticles to Enhance the Anticancer Efficacy in Gastric Cancers.
Li T; Zhang Y; Meng YP; Bo LS; Ke WB
Pharm Res; 2017 Dec; 34(12):2710-2719. PubMed ID: 29181687
[TBL] [Abstract][Full Text] [Related]
15. Polymer-lipid hybrid nanoparticles-based paclitaxel and etoposide combinations for the synergistic anticancer efficacy in osteosarcoma.
Duan R; Li C; Wang F; Yangi JC
Colloids Surf B Biointerfaces; 2017 Nov; 159():880-887. PubMed ID: 28892872
[TBL] [Abstract][Full Text] [Related]
16. N-octyl-N-arginine-chitosan (OACS) micelles for gambogic acid oral delivery: preparation, characterization and its study on in situ intestinal perfusion.
Yu F; He C; Waddad AY; Munyendo WL; Lv H; Zhou J; Zhang Q
Drug Dev Ind Pharm; 2014 Jun; 40(6):774-82. PubMed ID: 23679668
[TBL] [Abstract][Full Text] [Related]
17. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery.
Zhang ZH; Wang XP; Ayman WY; Munyendo WL; Lv HX; Zhou JP
Drug Deliv; 2013 Feb; 20(2):86-93. PubMed ID: 23495734
[TBL] [Abstract][Full Text] [Related]
18. Transferrin-conjugated polymeric nanomedicine to enhance the anticancer efficacy of edelfosine in acute myeloid leukemia.
Sun Y; Sun ZL
Biomed Pharmacother; 2016 Oct; 83():51-57. PubMed ID: 27470549
[TBL] [Abstract][Full Text] [Related]
19. Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles.
Wang C; Zhang H; Chen B; Yin H; Wang W
Int J Nanomedicine; 2011; 6():1929-35. PubMed ID: 21931488
[TBL] [Abstract][Full Text] [Related]
20. Gambogic acid-loaded electrosprayed particles for site-specific treatment of hepatocellular carcinoma.
Yin D; Yang Y; Cai H; Wang F; Peng D; He L
Mol Pharm; 2014 Nov; 11(11):4107-17. PubMed ID: 25290462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
